Drugs / PHY906
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00411762 | Dec 2006 → Dec 2009 | malignant pancreatic neoplasm | Yale University | Completed | No outcome recorded |
| Phase 1/2 | NCT00076609 | Oct 2003 → ? | hepatocellular carcinoma | PhytoCeutica | Completed | No outcome recorded |
| Phase 1/2 | NCT00036517 | Feb 2002 → Mar 2003 | colorectal cancer, diarrheal disease | PhytoCeutica | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PHY906 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00411762 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “The botanical drug PHY906--currently manufactured pursuant to GMP standards and regulations--has been used in China for over 1800 years to treat gastrointestinal-related ailments.” NCT00076609 ↗ |
| Route | Oral | “PHY906 800mg, orally, twice a day” NCT00411762 ↗ |